Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225452 · ClinicalTrials.gov registry record
An Exosomal miRNA-based Liquid Biopsy for ICC Detection
A clinical trial, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 535
- Enrollment target
NCT07225452 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 535 participants.
The verdict
NCT07225452 has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 535 participants
- Enrollment target
Study Summary
Intrahepatic cholangiocarcinoma (ICC) is a malignant liver tumor with poor prognosis and limited curative treatment options. Early and accurate detection remains an unmet clinical need. The LUMIC study aims to develop a non-invasive liquid biopsy platform based on both exosomal microRNAs (exo-miRNAs) to detect intrahepatic cholangiocarcinoma with high sensitivity and specificity.
Interventions
- DIAGNOSTIC_TEST Small RNA sequencing
- DIAGNOSTIC_TEST LUMIC assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 535 participants |
| Start Date | 2024-06-21 |
| Est. Completion | 2026-02-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07225452
The ClinicalTrials.gov registry entry for NCT07225452 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 535 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Small RNA sequencing is the first listed.
NCT07225452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07225452 about?
NCT07225452 is a clinical study titled "An Exosomal miRNA-based Liquid Biopsy for ICC Detection". Intrahepatic cholangiocarcinoma (ICC) is a malignant liver tumor with poor prognosis and limited curative treatment options. Early and accurate detection remains an unmet clinical need. The LUMIC study aims to develop a non-invasive liquid biopsy platform based on both exosomal microRNAs (exo-miRNA...
What is the current status of trial NCT07225452?
This trial is currently completed. The enrollment target is 535 participants. The study started on 2024-06-21. Estimated completion is 2026-02-05.
What interventions are being tested in trial NCT07225452?
The interventions under investigation include: Small RNA sequencing (DIAGNOSTIC_TEST), LUMIC assay (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07225452?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.